Markets · Global Equities · US

Aclaris Therapeutics, Inc. ACRS

Exchange Nasdaq. Sector Pharma & biotech. Source: SEC companyfacts. Not a price feed.

• Revenue TTM 8.40M
• EBITDA TTM -84.49M
• Net debt -9.66M
• ND/EBITDA 0.11
• EBITDA/interest —
• ROE -0.45
• Implied band BB

All countries